South Korea Digital Therapeutics/DTx Market (2026-2031)
The South Korea Digital Therapeutics/DTx Market was valued at $129.4 Million in 2026 and projected to reach to $421.9 Million by 2031, representing a compound annual growth rate of 26.7%. South Korea's digital therapeutics market is positioned for exceptional growth through 2031, driven by its world-class healthcare system, technological expertise, and increasing healthcare costs that incentivize digital solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Digital Therapeutics/DTx Market Trends and Insights
- This represents a compound annual growth rate of 26.7%, reflecting South Korea's advanced healthcare infrastructure and strong adoption of digital health solutions.
- South Korea's position as a technology leader in Asia Pacific is driving significant investment in DTx platforms for chronic disease management, mental health, and behavioral interventions. The South Korean DTx market benefits from high smartphone penetration, government healthcare digitalization initiatives, and increasing reimbursement pathways for digital therapeutics.
- South Korea's aging population and rising prevalence of lifestyle diseases are creating substantial demand for scalable, cost-effective treatment alternatives.
- South Korea's regulatory environment, supported by the Ministry of Food and Drug Safety, continues to streamline approval processes for innovative DTx solutions, positioning the country as a regional hub for digital health innovation..
Key Market Statistics
- CAGR (2026-2031) 26.7% CAGR
- Market Size, 2026 ~USD 129.4 Million
- Forecast, 2031 ~USD 421.9 Million
- Country South Korea
South Korea Digital Therapeutics/DTx Market Overview
Rapid Market Expansion :
South Korea's digital therapeutics market is projected to grow from $129.4 million in 2026 to $421.9 million by 2031, representing a 26.7% CAGR, outpacing the global average of 26.4%.
Tech-Driven Healthcare Adoption :
South Korea's advanced digital infrastructure and high smartphone penetration enable rapid adoption of DTx solutions across mental health, chronic disease management, and rehabilitation sectors.
Regulatory Support & Innovation :
South Korea's progressive regulatory framework and government initiatives supporting digital health innovation create a favorable environment for DTx companies and clinical validation studies.
Asia Pacific Leadership :
As a technology leader in Asia Pacific, South Korea is establishing itself as a hub for DTx development, attracting regional investments and serving as a model for neighboring markets.
South Korea Digital Therapeutics/DTx Market Dynamics
- The country's aging population and rising prevalence of chronic diseases create substantial demand for innovative DTx applications in diabetes management, cardiovascular health, and mental wellness.
- Government support for digital health initiatives and strong reimbursement pathways are accelerating market penetration.
- South Korea's competitive advantage as a technology innovator ensures continued investment in DTx research and development.
- The market will likely see increased collaboration between local tech companies, healthcare providers, and pharmaceutical firms, positioning South Korea as a regional leader in digital therapeutics adoption and commercialization..
Market Ecosystem
DIGITAL THERAPEUTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
AI-enabled virtual care, chronic disease management, remote patient monitoring (RPM), and integrated digital therapeutics platform | Improved patient engagement, reduced hospitalizations, enhanced chronic disease outcomes, and expanded access to virtual care |
 |
AI-powered behavior change platform, digital weight management, nutrition coaching, and personalized lifestyle interventions | Sustainable weight loss, improved metabolic health, higher patient adherence, and reduced risk of chronic diseases |
 |
AI-driven musculoskeletal (MSK) digital therapy, wearable-enabled motion tracking, computer vision, and virtual physical therapy | Faster recovery, reduced pain, lower musculoskeletal treatment costs, and decreased need for surgery or opioid use |
 |
Digital chronic disease prevention and management platform for diabetes, hypertension, obesity, and cardiovascular health using connected devices and personalized coaching | Improved clinical outcomes, better disease control, increased medication adherence, and reduced healthcare expenditures |
 |
AI-powered digital therapeutics platform integrating glucose monitoring, blood pressure monitoring, behavioral health, and personalized coaching | Better disease self-management, improved patient outcomes, enhanced engagement, and lower total cost of care |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- South Korea's DTx market will grow from $129.4M (2026) to $421.9M (2031) at a 26.7% CAGR, outpacing global growth rates.
- South Korea's advanced digital infrastructure and high tech adoption enable rapid DTx deployment across mental health, diabetes, and cardiovascular applications.
- South Korea's government-backed healthcare digitalization and expanding reimbursement policies are accelerating DTx market penetration.
- South Korea's aging demographic and chronic disease burden create sustained demand for scalable digital therapeutic solutions through 2031.
Digital Therapeutics/DTx Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IMMERSIVE & INTERFACE-BASED THERAPEUTICS (Offering) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 26.4% from 2026 to 2031 |
| Largest Segment | B2B SALES CHANNELS (Sales Channel) |
| Market Size Base Year (Billions) | ~USD 10.96 (2026) |
| Revenue Forecast (Billions) | ~USD 35.37 (2031) |
| Segments Covered | Offering, Product Type, Application, Type, Revenue Model, Sales Channel, End User |
South Korea Digital Therapeutics/DTx Market Report Segmentation
7 segment dimensions are covered across the global market.
By Offering
- Immersive & Interface-Based Therapeutics
- Software/Platforms
- Therapeutic Programs
By Product Type
- Non-Prescription Digital Therapeutics
- Prescription Digital Therapeutics
By Application
- Preventive Applications
- Treatment & Care-Related Applications
By Type
- Cardiovascular Diseases
- Central Nervous System (Cns) Disorders
- Chronic Respiratory Diseases
- Diabetes
- Diagnostic & Rehabilitation Centers
- Hospitals
- Medication Adherence
- Musculoskeletal Disorders
- Nutrition & Lifestyle Management
- Obesity & Weight Management
- Other Healthcare Providers
- Other Preventive Applications
- Other Treatment & Care-Related Applications
- Prediabetes
- Private Payers
- Public Payers
- Rehabilitation & Patient Care
- Sleep Disorders
- Smoking Cessation
- Specialty Clinics
- Substance Use Disorders & Addiction Management
By Revenue Model
- Licensing (Enterprise/SaaS) Models
- Outcome-/Value-Based Models
- Subscription-Based Models
By Sales Channel
- B2B Sales Channels
- B2C Sales Channels
By End User
- Employers
- Healthcare Payers
- Healthcare Providers
- Other End Users
- Patients/Individuals
Target Audience
- DTx Companies & Startups : Evaluate South Korea as a market entry or expansion opportunity with detailed growth forecasts, competitive positioning, and regulatory requirements specific to the Korean market.
- Healthcare Providers & Hospitals : Understand DTx adoption trends, clinical efficacy data, and reimbursement models in South Korea to make informed procurement and integration decisions for digital health solutions.
- Pharmaceutical & Medical Device Companies : Identify DTx partnership and acquisition opportunities in South Korea's growing market, assess competitive threats, and develop complementary digital health strategies.
- Healthcare Investors & PE Firms : Access market sizing, growth projections, and investment landscape analysis for South Korea to identify high-potential DTx companies and portfolio opportunities in Asia Pacific.
- Government & Healthcare Policy Makers : Leverage market data and trend analysis to inform digital health policy, reimbursement frameworks, and innovation initiatives aligned with South Korea's healthcare transformation goals.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation ($129.4M in 2026) and verified forecasts ($421.9M by 2031) specific to South Korea, enabling accurate business planning and investment decisions in this high-growth market.
- Competitive Landscape Intelligence : Understand South Korea's unique competitive dynamics, local player strategies, and market entry barriers to develop effective go-to-market strategies and identify partnership opportunities.
- Regulatory & Reimbursement Insights : Access detailed analysis of South Korea's progressive regulatory environment, reimbursement pathways, and government support mechanisms that differentiate this market from global competitors.
- Segment & Application Analysis : Identify high-opportunity DTx segments in South Korea including mental health, chronic disease management, and rehabilitation with specific adoption rates and revenue projections.
- Strategic Investment Guidance : Make informed investment and expansion decisions with country-specific insights on market drivers, growth catalysts, and risk factors unique to South Korea's digital therapeutics ecosystem.
Frequently asked questions
What is the projected market size of digital therapeutics in South Korea by 2031?
South Korea's DTx market is projected to reach $421.9 million by 2031, growing from $129.4 million in 2026 at a 26.7% CAGR.
What are the primary drivers of DTx adoption in South Korea?
South Korea's DTx growth is driven by high smartphone penetration, government healthcare digitalization initiatives, expanding reimbursement pathways, and an aging population with rising chronic disease prevalence.
Which therapeutic areas are leading DTx adoption in South Korea?
South Korea's leading DTx applications include mental health, diabetes management, cardiovascular disease, and behavioral health interventions, supported by strong digital health infrastructure.
How does South Korea's regulatory environment support DTx market growth?
South Korea's Ministry of Food and Drug Safety has streamlined approval processes for digital therapeutics, creating a favorable regulatory pathway that accelerates market entry and innovation.
What role does reimbursement play in South Korea's DTx market expansion?
South Korea's expanding reimbursement policies and insurance coverage for digital therapeutics are critical enablers of market growth, improving patient access and provider adoption rates.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital therapeutics market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.
Primary Research
In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital therapeutics market. Primary sources from the demand side included personnel from healthcare providers, payers, employees, and patients/individuals.
Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue, as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the digital therapeutics market was determined after data triangulation through the two approaches mentioned below. After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach.
Global Digital Therapeutics Market Size: Top-down Approach and Bottom-up Approach
Data Triangulation
The size of the digital therapeutics market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as given below:
- Revenues for individual companies were gathered from public sources and databases.
- Shares of leading players in the digital therapeutics market were gathered from secondary sources to the extent available. In certain cases, shares of digital therapeutics businesses have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach & strength.
- Individual shares or revenue estimates were validated through interviews with experts.
- The total revenue in the digital therapeutics market was determined by extrapolating the market share data of major companies.
Market Definition
The digital therapeutics market comprises evidence-based, clinically validated software solutions designed to prevent, manage, or treat medical conditions through therapeutic interventions delivered via digital technologies. These solutions are delivered through mobile applications, web-based platforms, connected devices, and immersive technologies, and may be prescribed by healthcare professionals or accessed directly by consumers. By leveraging data analytics, artificial intelligence (AI), and personalized behavioral interventions, digital therapeutics improve clinical outcomes, enhance patient engagement, and support the prevention and management of acute and chronic diseases.
Key Stakeholders
- Digital therapeutics developers and platform providers
- Pharmaceutical and biotechnology companies
- Healthcare providers (hospitals, specialty clinics, rehabilitation centers, and primary care centers)
- Health insurance companies (public and private payers)
- Employers and corporate wellness providers
- Medical device and wearable technology companies
- Academic medical centers, universities, and research institutions
- Regulatory agencies and health technology assessment (HTA) bodies
- Government and public health organizations
- Telehealth and digital health platform providers
- Electronic health record (EHR) and healthcare IT solution providers
- Investors, venture capital firms, and private equity firms
- Patients and patient advocacy organizations
- Business research and consulting service providers
Report Objectives
- To define, describe, and forecast the digital therapeutics market based on offering, product type, application, revenue model, sales channel, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall digital therapeutics market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital therapeutics market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific digital therapeutics market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
- Further breakdown of the Rest of Europe digital therapeutics market into Russia, Austria, Finland, Sweden, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries
Get the Full Digital Therapeutics/DTx Market Report
Full forecast, segment splits, and company analysis for all Digital Therapeutics/DTx Market.
- US Digital Therapeutics/DTx Market
- Canada Digital Therapeutics/DTx Market
- Germany Digital Therapeutics/DTx Market
- France Digital Therapeutics/DTx Market
- UK Digital Therapeutics/DTx Market
- Italy Digital Therapeutics/DTx Market
- Spain Digital Therapeutics/DTx Market
- China Digital Therapeutics/DTx Market
- Japan Digital Therapeutics/DTx Market
- India Digital Therapeutics/DTx Market
- Australia Digital Therapeutics/DTx Market
- Brazil Digital Therapeutics/DTx Market
- Mexico Digital Therapeutics/DTx Market
- Saudi Arabia Digital Therapeutics/DTx Market
- UAE Digital Therapeutics/DTx Market
- South Africa Digital Therapeutics/DTx Market
- Rest Of Europe Digital Therapeutics/DTx Market
- Rest Of Asia Pacific Digital Therapeutics/DTx Market
- Rest Of Latin America Digital Therapeutics/DTx Market
- GCC Countries Digital Therapeutics/DTx Market
- Rest Of GCC Countries Digital Therapeutics/DTx Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
